OakChart

DaVita Inc

DVAHealthcare·Medical Care Facilities·USA·Large·NYSE·Nov 11 • 1:21 PM ET

179.33+0.05 (0.03%)
2026-11-11 19:22 CET
Market cap
11,276.71 USD m
Revenue, TTM
14,167.55 USD m
Net income, TTM
895.08 USD m
Free cash flow, TTM
1,294.06 USD m
EPS diluted, TTM
13.22
P/E
13.56
Compare

Price

DVA against its 20, 50 and 200-day averages
2050200beatmiss
150.00200.00250.001.9M3.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DVAclose 179.3320-day 185.3450-day 182.82200-day 180.21179.3352w high

27.5% under the 52-week high of 247.49 on 3 Aug 2026. 52-week low 101.00 on 14 Jan 2026. Last 15 sessions, 15.1% high to low

Profile

DVA
52-week range, 53% of the way up
101247.49

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

IndexS&P 500, RUI
Employees78000
IPOOct 31, 1995
Beta0.86
ATR, 14d7.08
Rel volume0.46
Short float8.35%
Insider own2.08%
Inst own94.67%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap11.28B
Enterprise Value25.74B
Income895.08M
Sales14.17B
Book/sh-9.32
Cash/sh10.33
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees78000
IPOOct 31, 1995

Ratios

P/E13.56
Forward P/E10.77
PEG0.49
P/S0.80
P/B-
P/C17.36
P/FCF8.72
EV/EBITDA9.04
EV/Sales1.82
Quick Ratio1.36
Current Ratio1.41
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)13.22
EPS next Y16.65
EPS next Q4.20
EPS this Y36.37%
EPS next Y13.28%
EPS next 5Y21.98%
EPS past 3/5Y18.56% 8.29%
Sales past 3/5Y5.53% 3.39%
EPS Y/Y TTM36.05%
Sales Y/Y TTM6.38%
EPS Q/Q67.00%
Sales Q/Q4.62%
EarningsOct 29 AMC
EPS/Sales Surpr.6.87% 1.74%

Ownership

Insider Own2.08%
Insider Trans-36.04%
Inst Own94.67%
Inst Trans-3.72%
ROA5.06%
ROE-
ROIC7.31%
Gross Margin27.35%
Oper. Margin15.17%
Profit Margin6.32%
SMA20-3.24%
SMA50-1.91%
SMA200-0.49%
Trades-

Technical

Shs Outstand63.40M
Shs Float61.59M
Short Float8.35%
Short Ratio7.09
Short Interest5.14M
52W High247.49 -27.54%
52W Low101.00 77.55%
Volatility3.49% 3.88%
ATR (14)7.08
RSI (14)44.81
Beta0.86
Rel Volume0.46
Avg Volume725.60K
Volume206,522

Performance

Perf Week-6.92%
Perf Month-1.51%
Perf Quarter0.09%
Perf Half Y-9.48%
Perf YTD57.85%
Perf Year46.67%
Perf 3Y116.08%
Perf 5Y68.97%
Perf 10Y201.24%
Recom2.36
Target Price231.83
Prev Close179.28
Price179.33
Change %0.03%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 07, 2026UpgradeTTD CowenHold → Buy$220+22.7%
May 06, 2026UpgradeDDeutsche BankHold → Buy$220+22.7%
Mar 06, 2024InitiatedBBarclaysEqual Weight$133-25.8%
Aug 07, 2023UpgradeUUBSNeutral → Buy$100 → $142-20.8%
Nov 01, 2022DowngradeDDeutsche BankBuy → Hold$97 → $72-59.9%
Oct 31, 2022DowngradeUUBSBuy → Neutral$117 → $74-58.7%
Aug 19, 2022ResumedUUBSBuy$106 → $117-34.8%
Jun 21, 2022ReiteratedBBofA SecuritiesUnderperform$110 → $90-49.8%
Sep 10, 2021InitiatedCCowenMarket Perform$145-19.1%
Aug 12, 2021DowngradeBBarclaysOverweight → Equal Weight$135 → $146-18.6%

Peers

Mkt cap
TickerCompanyMkt cap
FMSFresenius Medical Care AG ADR11.43B
THCTenet Healthcare Corp22.87B
EHCEncompass Health Corp13.89B
OPCHOption Care Health Inc4.74B
HCAHCA Healthcare Inc104.32B
UHSUniversal Health Services Inc11.22B
SGRYSurgery Partners Inc3.48B
ASTHAstrana Health Inc1.63B
OMOutset Medical Inc79.08M
RMTIRockwell Medical Inc28.80M

Insider trading

latest 14 of 24
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BERKSHIRE HATHAWAY INC10% OwnerOct 27 '26Sale180.43382,56369,026,03328,314,666Oct 29 05:21 PM
BERKSHIRE HATHAWAY INC10% OwnerJul 31 '26Sale199.55182,98036,513,29328,697,229Aug 04 05:27 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffJun 15 '26Sale208.4015,4053,210,377109,194Jun 17 06:10 PM
Rodriguez JavierChief Executive OfficerJun 16 '26Sale209.2839,4078,247,018840,408Jun 17 06:09 PM
Rodriguez JavierChief Executive OfficerJun 15 '26Sale209.5030,0006,285,090879,815Jun 17 06:09 PM
Javier RodgriguezOfficerJun 16 '26Proposed Sale209.2839,4078,247,016Jun 16 04:44 PM
Kathleen WatersOfficerJun 15 '26Proposed Sale207.848,9501,860,202Jun 15 04:53 PM
Javier RodriguezOfficerJun 15 '26Proposed Sale209.5030,0006,285,102Jun 15 04:48 PM
Waters Kathleen AlyceOfficerJun 15 '26Proposed Sale207.936,4551,342,188Jun 15 04:10 PM
HEARTY JAMES OChief Compliance OfficerMay 14 '26Option Exercise110.635,784639,88441,737May 18 04:08 PM
HEARTY JAMES OChief Compliance OfficerMay 15 '26Sale193.9815,0002,909,74522,389May 18 04:08 PM
James HeartyOfficerMay 15 '26Proposed Sale193.9315,0002,908,950May 15 03:12 PM
Maughan David PaulChief Operating Officer, DKCMay 12 '26Sale199.2513,4562,681,16294,105May 13 04:10 PM
Maughan David PaulChief Operating Officer, DKCMay 11 '26Sale199.157,0731,408,581107,561May 13 04:10 PM

Held by

AUM
TickerCompanyAUM
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
OMAHVistaShares Target 15 Berkshire Select Income ETFAUM: 1.11B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-293.8203.5753.4003,5783,5177
2026Q22026-08-044.0203.8824.0163,5543,4966
2026Q12026-05-052.8702.3302.8683,4163,3566
2025Q42026-02-023.4003.2422.9363,6203,5067
2025Q32025-10-292.5103.2212.0383,4203,4357
2025Q22025-08-052.9502.7712.5773,3803,3636
2025Q12025-05-122.0001.9522.0053,2243,2075
2024Q42025-02-132.2402.1263.0933,2953,2627
2024Q32024-10-292.5902.7242.5023,2643,2476
2024Q22024-08-062.5902.5922.5033,1873,1526
2024Q12024-05-022.3801.9482.6473,0713,0286
2023Q42024-02-131.8701.6301.6243,1463,0085
2023Q32023-11-072.8502.0112.6233,1213,0195
2023Q22023-08-032.0801.7071.9133,0002,9527
2023Q12023-05-081.5801.1771.2492,8732,8385
2022Q42023-02-221.1100.9330.5952,9172,9315

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY3.5703.6230.92011,40511,541
2019FY5.4005.2625.27310,56311,411
2020FY7.2607.4546.38811,55111,572
2021FY9.1308.8868.89911,61911,587
2022FY6.6006.2075.70711,61011,624
2023FY8.4707.9777.42112,14012,007
2024FY9.6809.67710.72912,81612,780
2025FY10.78010.5629.84013,64313,529
2026FY-14.701--14,190
2027FY-16.653--14,664
2028FY-19.566--15,208
2029FY-18.115--15,893

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-306113,6453,6243,674
2026Q4S2026-10-296003,6133,4713,692
2026Q4S2026-10-196003,6133,4713,692
2026Q4S2026-10-096023,6133,4713,692
2026Q4S2026-09-216023,6133,4713,692
2026Q4S2026-08-065023,6113,4713,692
2026Q4S2026-08-055023,6153,4713,692
2026Q4S2026-07-225003,6513,5623,716
2026Q4S2026-06-065013,6513,5623,716
2026Q4S2026-05-086013,6413,5623,716
2026Q4S2026-05-066003,6513,5623,716
2026Q4S2026-04-205003,6363,5813,711
2026Q4S2026-04-195103,6363,5813,711
2026Q4S2026-02-265203,6363,5813,711

Estimate history

EPS, annual3.470.925.2736.3888.8995.7077.42110.7299.51213.2228
Period201720182019202020212022202320242025TTM
EPS, quarterly2.5023.0932.0052.5772.0382.9362.8684.0163.403
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual10876.63411404.85111388.47911550.60411618.79711609.89412140.14712815.5513643.06914167.55
Period201720182019202020212022202320242025TTM
Sales, quarterly3263.593294.6833223.5293379.5263420.2273619.7873415.5483554.0843578.126
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual182.462166.387125.843109.93397.28990.41188.82480.53668.54963.4
Period201720182019202020212022202320242025MRQ
Shares, quarterly82.62480.53677.27774.21770.97768.54966.18563.95563.4
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue14,167.5513,643.0712,815.5512,140.1511,609.8911,618.8011,550.6011,388.4811,404.85
Cost of Goods Sold Incl. D&A10,292.359,958.829,322.389,065.168,942.168,653.038,619.058,529.648,775.55
Gross Profit3,875.203,684.243,493.173,074.992,667.742,965.772,931.562,858.842,629.30
Selling, General and Administrative Excl. Other1,726.431,673.631,538.341,473.981,355.201,195.341,247.581,103.311,128.15
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income2,148.762,010.621,954.831,601.001,312.541,770.431,683.971,755.531,501.15
Interest Expense578.14589.89412.29294.98345.29279.75297.03435.23478.97
Unusual Expense73.2414.18-89.6522.88-5.922.4886.39157.5126.71
Net Income Before Taxes1,517.711,346.821,530.391,177.09966.281,518.491,318.261,195.441,048.48
Income Taxes324.03293.11279.66220.12198.09306.73313.93279.63258.40
Consolidated Net Income1,193.681,053.721,250.74956.98768.191,211.761,004.33915.81790.08
Net Income From Continuing Operations895.08721.80936.34691.53546.95978.45783.29706.83624.32
Net Income895.08721.80936.34691.53546.95978.45783.29810.98159.39
EPS (Recurring)14.459.6410.017.595.668.916.885.991.03
EPS (Basic, Before Extraordinaries)13.529.7211.027.625.889.306.545.290.93
EPS (Diluted)13.229.5110.737.425.718.906.395.270.92
EBITDA2,846.292,725.962,678.692,346.452,045.142,451.052,314.412,370.682,092.18
Non-Operating Income (Expense)20.32-59.72-101.79-106.05-6.9030.2817.7132.6553.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense91.90123.4186.3995.8480.7088.3679.6858.6659.47
Price To Earnings Ratio13.5613.5616.1216.4210.9312.8218.3913.9964.72
Price To Sales Ratio0.810.631.020.800.621.081.251.010.78
Gross Margin27.3527.0027.2625.3322.9825.5325.3825.1023.05
Operating Margin15.1714.7415.2513.1911.3115.2414.5815.4113.16
Net Margin6.325.297.315.704.718.426.787.121.40
Shares Outstanding63.4068.5580.5488.8290.4197.29109.93125.84166.39
Market Capitalization11,276.7111,276.7112,263.109,564.596,727.7711,592.1413,148.809,612.248,541.54

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,578.133,554.083,415.553,619.793,420.233,379.533,223.533,294.68
Cost of Goods Sold Incl. D&A2,616.242,559.812,520.092,596.222,510.252,436.242,416.112,399.47
Gross Profit961.89994.27895.461,023.57909.98943.28807.42895.21
Selling, General and Administrative Excl. Other408.70423.46421.91472.36414.37412.81374.09414.48
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income553.19570.82473.55551.21495.61530.48433.33480.73
Interest Expense146.18146.42141.30144.24148.66144.02133.05141.22
Unusual Expense62.182.040.009.035.150.000.00-74.32
Net Income Before Taxes358.71435.01341.23382.76308.80368.93286.33413.73
Income Taxes89.3291.7966.2076.7368.5593.7154.1264.49
Consolidated Net Income269.39343.22275.04306.03240.25275.22232.22349.25
Net Income From Continuing Operations222.93265.40197.53209.22150.33199.34162.92259.33
Net Income222.93265.40197.53209.22150.33199.34162.92259.33
EPS (Recurring)4.074.042.873.022.092.582.002.47
EPS (Basic, Before Extraordinaries)3.494.102.933.002.092.622.053.18
EPS (Diluted)3.404.022.872.942.042.582.003.09
EBITDA718.38738.62651.38737.91673.10705.18609.78654.83
Non-Operating Income (Expense)13.8712.658.98-15.18-33.00-17.53-13.95-0.09
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense21.2518.5321.0231.1130.5925.6623.2021.31
Price To Earnings Ratio13.5621.3516.0811.7013.0614.1014.2416.12
Price To Sales Ratio0.811.050.770.590.740.840.960.98
Gross Margin26.8827.9826.2228.2826.6127.9125.0527.17
Operating Margin15.4616.0613.8615.2314.4915.7013.4414.59
Net Margin6.237.475.785.784.405.905.057.87
Shares Outstanding63.4063.9566.1968.5570.9874.2277.2880.54
Market Capitalization11,276.7114,283.2210,266.498,020.879,500.2010,754.9812,237.6012,263.10

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments782.05930.89476.24416.68577.27521.891,220.29418.36551.75
Short Term Receivables2,959.042,557.682,415.912,550.652,410.512,438.822,305.072,397.022,163.45
Inventories160.63134.56143.10109.12107.43111.6297.95107.38181.80
Other Current Assets156.28122.95102.6478.8472.5276.3966.875,501.405,873.70
Total Current Assets4,058.003,746.073,137.913,155.293,167.723,148.723,690.178,424.168,770.70
Net Property, Plant & Equipment5,210.155,334.475,574.905,922.646,304.766,384.916,303.433,393.673,149.21
Total Investments and Advances209.81400.41593.74275.44288.39289.68278.50260.89284.26
Intangible Assets7,767.227,572.657,315.787,259.307,223.937,085.696,923.326,960.816,724.11
Deferred Tax Assets698.47732.90760.34779.21772.43773.65766.54209.58201.18
Other Assets165.19185.42236.82287.88113.7779.50115.9770.7346.26
Total Assets18,108.8317,971.9217,619.4817,679.7517,871.0117,762.1618,077.9319,319.8319,175.72
Short Term Debt Incl. Current Port. of LT Debt734.62681.28517.70626.80573.39538.04474.621,929.37178.21
Accounts Payable696.15547.20514.53479.78402.05434.25403.84463.27509.12
Income Tax Payable24.3610.3028.5118.0453.797.7742.41-0.00
Other Current Liabilities1,686.501,734.631,581.481,495.121,369.311,496.081,451.232,498.522,380.19
Total Current Liabilities3,141.632,973.412,642.212,619.752,398.532,476.142,372.104,891.163,067.52
Long Term Debt12,339.6511,385.5610,598.7211,195.6811,401.8610,655.9310,701.338,172.859,158.02
Provision for Risks Charges0.000.000.000.000.000.000.002.180.00
Deferred Tax Liabilities1,385.601,352.011,452.121,534.291,580.471,583.251,344.08772.12687.43
Other Liabilities83.52169.59183.07105.23119.16150.06160.81448.49365.32
Total Liabilities16,950.4015,880.5714,876.1315,454.9515,500.0314,865.3814,578.3114,286.8013,278.29
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-651.08121.121,056.10712.33755.511,383.572,133.413,703.444,690.03
Total Shareholders Equity-651.08121.121,056.10712.33755.511,383.572,133.413,703.444,690.03
Accumulated Minority Interest1,809.521,970.231,687.251,512.471,615.471,513.211,366.211,329.601,207.40
Total Equity1,158.442,091.352,743.352,224.802,370.982,896.783,499.625,033.045,897.43
Total Liabilities & Stockholders Equity18,108.8317,971.9217,619.4817,679.7517,871.0117,762.1618,077.9319,319.8319,175.72
Book Value Per Share-9.501.5011.897.887.7712.5916.9522.2625.70
Tangible Book Value Per Share-122.81-92.52-70.47-72.41-66.49-51.87-38.06-19.58-11.15
Full-Time Employees78,00076,00070,00070,00069,00067,00065,00077,70074,500
Price to Book Ratio-19.2331.957.9812.6314.659.334.432.312.86
Return on Assets4.005.263.923.085.494.373.783.254.70
Return on Equity-159.0878.2174.5291.4844.5424.2214.8819.30
Return on Invested Capital6.188.145.934.598.056.516.321.344.79
Quick Ratio1.241.211.131.161.281.231.511.702.80
Current Ratio1.291.261.191.201.321.271.561.722.86

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,218.681,078.721,250.74956.98781.641,211.76994.681,021.29333.04
Depreciation697.53715.35723.86745.44732.60680.62630.43615.15591.03
Other Funds (Non Cash)221.70270.64141.78206.34129.85121.60220.38309.92478.65
Funds from Operations2,246.702,151.282,058.541,869.411,568.432,074.462,086.341,988.091,676.39
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-375.89-263.24-29.82194.530.10-140.64-104.1786.8698.90
Income Taxes Payable81.3350.24-44.211.57-24.1036.92-87.3995.64-23.64
Cash from Operating Activities1,870.811,888.042,028.722,063.941,568.531,933.821,982.172,074.941,775.29
Capital Expenditures-576.75-575.86-555.44-567.99-603.43-641.47-674.54-766.55-987.14
Net Assets From Acquisitions-121.03-143.47-300.03-38.95-78.08-207.15-189.84-168.88-211.24
Sale of Fixed Assets and Businesses29.4745.0541.2296.34136.0596.1093.113,934.71202.53
Purchase or Sale of Investments-317.482.67-2.46-212.94-90.37-19.88-22.09-17.2310.80
Purchase of Investments-346.26-49.47-29.66-322.95-165.28-47.76-176.80-116.29-33.59
Sale Or Maturity of Investments28.7852.1427.20110.0074.9127.88154.7099.0544.39
Other Uses0.000.000.000.00-0.78-0.740.00423.81-240.79
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-985.79-671.62-816.71-723.53-636.61-773.15-793.383,405.86-1,225.84
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-1,609.08-1,769.71-1,365.48-272.22-802.23-1,538.63-1,458.44-2,372.43-1,147.93
Repurchase of Common Pref Stock-1,629.29-1,793.00-1,385.93-272.22-802.23-1,538.63-1,458.44-2,383.82-1,161.51
Sale of Common Pref Stock20.2223.2920.450.000.000.000.0011.3813.58
Proceedsfrom Stock Options0.000.000.000.000.000.000.0011.3813.58
Issuance or Reduction of Debt, Net484.30769.621,058.22-622.41-11.28745.16-169.38-2,080.19694.78
Change in Long Term Debt484.30769.621,058.22-622.41-11.28745.16-169.38-2,080.19694.78
Issuance of Long Term Debt4,413.445,558.466,573.442,398.552,393.111,606.283,940.9338,525.8559,934.75
Reduction of Long Term Debt-3,929.13-4,788.85-5,515.21-3,020.96-2,404.39-861.12-4,110.30-40,606.04-59,239.97
Net Financing Active Other Cash Flow24.46-359.56-471.08-329.05-305.31-304.03-254.09-233.12-196.44
Other Financing Activities Uses24.46-359.56-471.08-329.05-305.31-304.03-254.09-233.12-196.44
Cash from Financing Activities-1,100.32-1,359.65-778.34-1,223.67-1,118.82-1,097.50-1,881.91-4,685.75-649.60
Exchange Rate Effect-0.8521.15-18.488.91-29.07-10.01-13.81-1.76-3.35
Net Change in Cash-216.15-122.08415.19125.64-215.9753.17-706.93793.30-103.50
Free Cash Flow1,294.061,312.181,473.281,495.96965.101,292.361,307.631,308.40788.15
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow8.856.578.866.537.419.6811.018.8211.25
Deferred Taxes & Investment Tax Credit-86.57-57.84-39.35-75.6760.48240.8541.72273.66

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments649.93771.77748.71782.05825.94827.97
Short Term Receivables3,122.283,117.223,012.792,959.042,985.833,003.23
Inventories161.46151.53141.61160.63139.09146.29
Other Current Assets141.15149.11159.58156.28160.97110.33
Total Current Assets4,074.824,189.644,062.684,058.004,111.834,087.83
Net Property, Plant & Equipment5,165.385,179.365,151.455,210.155,176.475,193.07
Total Investments and Advances509.34247.20228.22209.81307.64359.05
Intangible Assets7,769.117,819.787,811.337,767.227,763.557,677.46
Deferred Tax Assets---698.47--
Other Assets297.86273.50245.68165.19196.41175.56
Total Assets17,816.5117,709.4917,499.3718,108.8317,555.8917,492.96
Short Term Debt Incl. Current Port. of LT Debt550.62556.66544.87734.62494.94611.69
Accounts Payable662.20715.87691.26696.15655.60594.40
Income Tax Payable23.1424.6237.4224.3626.4119.69
Other Current Liabilities1,650.801,558.271,593.911,686.501,840.181,707.75
Total Current Liabilities2,886.772,855.432,867.463,141.633,017.132,933.54
Long Term Debt12,841.8012,849.8112,675.9712,339.6512,283.3912,203.68
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities861.69825.72818.921,385.60742.45646.23
Other Liabilities100.4399.0988.8583.52172.19156.49
Total Liabilities16,690.6916,630.0516,451.2016,950.4016,215.1715,939.93
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-591.09-765.10-755.50-651.08-571.87-369.63
Total Shareholders Equity-591.09-765.10-755.50-651.08-571.87-369.63
Accumulated Minority Interest1,716.901,844.531,803.661,809.521,912.601,922.66
Total Equity1,125.821,079.441,048.171,158.441,340.721,553.02
Total Liabilities & Stockholders Equity17,816.5117,709.4917,499.3718,108.8317,555.8917,492.96
Book Value Per Share-9.32-11.96-11.41-9.50-8.06-4.98
Tangible Book Value Per Share-131.86-134.23-129.44-122.81-117.44-108.43
Full-Time Employees---78,000--
Price to Book Ratio-19.23-19.49-16.18-14.10-26.68-41.21
Return on Assets5.064.674.374.004.404.85
Return on Equity-----635.30
Return on Invested Capital1.822.201.661.791.281.68
Quick Ratio1.361.411.371.241.321.34
Current Ratio1.411.471.421.291.361.39

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income269.39343.22275.04331.03240.25275.22
Depreciation165.19167.81177.83186.70177.49174.70
Other Funds (Non Cash)87.9838.5134.9560.2691.6760.24
Funds from Operations560.34548.17542.61595.58588.23496.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-41.28-58.11-221.67-54.83253.34-171.60
Income Taxes Payable32.98-59.6627.1280.88-40.10-30.37
Cash from Operating Activities519.05490.07320.94540.75841.57324.39
Capital Expenditures-159.49-169.82-102.02-145.43-166.09-121.09
Net Assets From Acquisitions-55.17-5.11-52.01-8.74-118.75-0.35
Sale of Fixed Assets and Businesses12.300.867.778.5411.3612.30
Purchase or Sale of Investments-269.59-20.49-6.98-20.431.3242.40
Purchase of Investments-285.67-20.54-12.25-27.8110.96-3.26
Sale Or Maturity of Investments16.080.055.277.38-9.6445.65
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-471.95-194.55-153.23-166.06-272.15-66.75
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-100.92-360.82-393.93-753.40-231.38-279.70
Repurchase of Common Pref Stock-109.52-364.35-396.31-759.11-240.05-283.67
Sale of Common Pref Stock8.603.522.395.718.673.98
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-19.54156.05343.214.58-26.25510.47
Change in Long Term Debt-19.54156.05343.214.58-26.25510.47
Issuance of Long Term Debt737.121,503.321,260.30912.71481.173,537.80
Reduction of Long Term Debt-756.65-1,347.27-917.09-908.12-507.42-3,027.34
Net Financing Active Other Cash Flow-99.05-65.11-148.59337.21-314.95-226.91
Other Financing Activities Uses-99.05-65.11-148.59337.21-314.95-226.91
Cash from Financing Activities-219.51-269.89-199.31-411.61-572.583.87
Exchange Rate Effect-0.19-0.180.26-0.751.6110.87
Net Change in Cash-172.6025.45-31.34-37.67-1.54272.39
Free Cash Flow359.56320.25218.92395.32675.49203.30
Price to Free Cash Flow8.859.137.096.177.588.54

Revenue breakdown

United States2024: 12.82B 2025: 13.64B
Other Operating2024: 1.50B 2025: 1.91B
U S Dialysis And Related Lab Services2024: 11.32B 2025: 11.73B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.35%5.1M61.6M822.56K
2026-10-157.85%4.9M62.5M751.98K
2026-09-308.24%5.1M62.5M800.24K
2026-09-156.88%4.3M62.5M819.76K
2026-08-317.49%4.7M62.5M840.62K
2026-08-146.41%4.0M62.5M888.91K
2026-07-316.86%4.3M62.5M860.76K
2026-07-157.15%4.5M62.9M871.40K
2026-06-307.22%4.5M62.9M854.28K
2026-06-157.36%4.6M62.8M843.98K
2026-05-297.72%4.9M62.9M871.58K
2026-05-159.03%5.7M62.9M865.14K
2026-04-309.96%6.3M62.7M995.57K
2026-04-159.06%5.9M65.3M1.05M
2026-03-319.79%6.2M63.2M1.09M
2026-03-139.27%5.9M63.2M1.07M
2026-02-279.57%6.0M63.2M1.03M
2026-02-1310.38%6.6M63.2M1.09M
2026-01-3010.13%6.8M66.8M921.22K
2026-01-1510.40%6.9M66.8M907.54K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call11562.7065.4072.301.42711.000.000.973-0.1670.018
call12057.7060.4067.301.6159.000.000.971-0.1640.019
call12552.5055.5058.801.53812.000.000.968-0.1620.020
call13047.6050.5050.601.3762.000.000.965-0.1590.022
call13542.5046.1052.501.4031.000.000.962-0.1560.023
call14037.8040.4054.401.1060.000.000.957-0.1520.026
call14532.7035.5036.300.9878.000.000.952-0.1480.028
call15027.7030.6031.400.8588.000.000.946-0.1440.031
call15522.8026.3032.500.8904.000.000.902-0.2230.049
call16018.0021.4027.900.7206.000.000.886-0.2100.054
call16514.1016.1026.550.58774.000.000.859-0.1980.063
call1709.6011.7010.000.52715.005.000.758-0.2710.088
call1756.307.7021.000.47232.000.000.654-0.2630.104
call1803.704.804.340.4463691.000.501-0.2910.112
call1851.552.953.830.4582090.000.353-0.2750.104
call1900.651.651.380.4606550.000.239-0.2400.087
call1950.150.850.500.4603,54112.000.143-0.1720.064
call2000.050.500.270.48348013.000.083-0.1180.043
call2100.002.200.450.6412,9680.000.066-0.1300.036
call2200.001.100.300.7794160.000.056-0.1390.032
call2300.002.150.300.9162190.000.049-0.1470.029
call2400.000.051.090.71225.000.000.008-0.0220.006
call2500.002.150.050.83437.000.000.007-0.0250.005
call2600.002.150.750.9172.000.000.006-0.0260.005
call2700.002.150.850.9972.000.000.006-0.0260.005
call2800.002.150.001.0770.000.000.005-0.0260.004
call2900.002.154.701.1521.000.000.005-0.0270.004
call3000.002.150.001.2190.000.000.005-0.0270.004
call3100.002.150.001.2860.000.000.005-0.0280.004
call3200.002.153.231.3517.000.000.004-0.0280.004
call3300.002.150.001.4140.000.000.004-0.0280.004
call3400.002.150.001.4750.000.000.004-0.0280.003
call3500.002.150.001.5330.000.000.004-0.0290.003
call3600.002.150.001.5890.000.000.004-0.0290.003
put1150.000.950.151.5784.000.00-0.027-0.1540.018
put1200.002.150.101.44846.000.00-0.029-0.1510.019
put1250.000.750.201.32210.000.00-0.032-0.1480.020
put1300.000.750.061.20054.000.00-0.035-0.1450.022
put1350.002.150.601.0665.000.00-0.039-0.1400.024
put1400.002.150.061.46832.000.00-0.115-0.4430.055
put1450.002.200.710.83814.000.00-0.049-0.1310.028
put1500.050.500.150.7413380.00-0.054-0.1270.031
put1550.001.150.400.76485.000.00-0.099-0.2060.049
put1600.051.250.250.6403690.00-0.115-0.1920.054
put1650.351.050.750.5153400.00-0.141-0.1800.063
put1700.951.501.500.44619824.00-0.214-0.2070.082
put1752.202.703.400.4203512.00-0.339-0.2420.103
put1803.905.305.360.44455.002.00-0.506-0.2710.112
put1857.108.403.800.4623790.00-0.647-0.2540.104
put19011.0013.0011.200.5661191.00-0.761-0.2180.087
put19515.2018.0013.000.70253.000.00-0.851-0.1570.065
put20019.8022.7020.000.78111.000.00-0.917-0.0950.043
put21030.1032.6028.900.95618.000.00-0.934-0.1070.036
put22040.2042.6039.801.1252.000.00-0.944-0.1150.032
put23049.6052.6039.801.3180.000.00-0.951-0.1210.029
put24059.7062.2057.901.3990.000.00-0.9920.0020.006
put25069.5072.2070.101.5380.000.00-0.9930.0030.005
put26078.5081.9071.001.5330.000.00-0.9940.0030.005
put27089.5092.6088.501.8710.000.00-0.9940.0040.005
put28099.20102.20.001.9070.000.00-0.9950.0050.004
put290110.2112.60.002.0380.000.00-0.9950.0050.004
put300119.9122.20.002.0950.000.00-0.9950.0060.004
put310129.4132.20.002.2230.000.00-0.9950.0070.004
put320139.9141.90.002.2130.000.00-0.9960.0080.004
put330150.2152.60.002.4330.000.00-0.9960.0090.004
put340159.3161.91102.3900.000.00-0.9960.0090.003
put350170.2172.60.002.6080.000.00-0.9960.0100.003
put360180.2182.60.002.7200.000.00-0.9960.0110.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-16144Filing for proposed sale of securities under Rule 144.SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-06-088-KCurrent report2026-06-04SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100069.03M1
2026-090000
2026-080000
2026-070036.51M1
2026-060017.74M3
2026-0500200.13M6
2026-040000
2026-030000
2026-020000
2026-0100199.94M1
2025-120000
2025-110000

Institutional holders

Manager% owned
BERKSHIRE HATHAWAY INC44.98%
BlackRock, Inc.3.83%
VANGUARD CAPITAL MANAGEMENT LLC3.27%
MORGAN STANLEY2.49%
VANGUARD PORTFOLIO MANAGEMENT LLC2.15%
STATE STREET CORP2.06%
GEODE CAPITAL MANAGEMENT, LLC1.97%
Invesco Ltd.1.89%
DIMENSIONAL FUND ADVISORS LP1.87%
Neuberger Berman Group LLC1.44%

Funds

Fund% owned
PGIM High Yield Fund188.68%
iShares Broad USD High Yield Corporate Bond ETF91.30%
Franklin Income Fund62.31%
Loomis Sayles Investment Grade Bond Fund59.52%
Fidelity Advisor Floating Rate High Income Fund55.53%
LORD ABBETT BOND DEBENTURE FUND INC55.46%
Fidelity Capital and Income Fund49.09%
VANGUARD HIGH-YIELD CORPORATE FUND46.72%
iShares 0-5 Year High Yield Corporate Bond ETF36.18%
Virtus Income & Growth Fund35.73%

OakChart. DVA. Cached 15 minutes.